Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

US Patent 11542323 · Granted Jan 3, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Antibodies that bind PSMA and gamma-delta T cell receptors2025
Agents, uses and methods for the treatment of synucleinopathy2025
Agents, uses and methods for the treatment of synucleinopathy2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Binding agents binding to EpCAM and CD1372025
Compositions and methods for treating synucleinopathies2025
Compositions and methods for treating synucleinopathies2025
Compositions and methods for treating synucleinopathies2025